Chagas Disease Treatment Efficacy Biomarkers: Myths and Realities
Author:
Publisher
Springer International Publishing
Link
http://link.springer.com/content/pdf/10.1007/978-3-030-00054-7_16
Reference99 articles.
1. Pinazo M-J, Thomas M-C, Bustamante J, ICd A, Lopez M-C, Gascon J. Biomarkers of therapeutic responses in chronic Chagas disease: state of the art and future perspectives. Mem Inst Oswaldo Cruz. 2015;110:422–32.
2. Pinazo MJ, Thomas MC, Bua J, Perrone A, Schijman AG, Viotti RJ, Ramsey JM, Ribeiro I, Sosa-Estani S, Lopez MC, Gascon J. Biological markers for evaluating therapeutic efficacy in Chagas disease, a systematic review. Expert Rev Anti-Infect Ther. 2014;12:479–96. https://doi.org/10.1586/14787210.2014.899150 .
3. Pinho RT, Waghabi MC, Cardillo F, Mengel J, Antas PR. Scrutinizing the biomarkers for the neglected Chagas disease: how remarkable! Front Immunol. 2016;7:306. https://doi.org/10.3389/fimmu.2016.00306 .
4. Chagas C. Nova tripanozomiaze humana: estudos sobre a morfolojia e o ciclo evolutivo do Schizotrypanum cruzi n. gen., n. sp., ajente etiolojico de nova entidade morbida do homem. Mem Inst Oswaldo Cruz. 1909;1:159–218.
5. Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115:14–21.
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Chagas disease treatment efficacy markers: experiences from a Phase III study with nifurtimox in children;Frontiers in Parasitology;2023-09-22
2. Rapid Test and Chagas Disease: An Overview;Rapid Antigen Testing;2023-02-10
3. Human Trypanosoma cruzi chronic infection leads to individual level steady-state parasitemia: Implications for drug-trial optimization in Chagas disease;PLOS Neglected Tropical Diseases;2022-11-21
4. Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs?;Expert Opinion on Drug Discovery;2022-08-29
5. Incidence and Predictors of Progression to Chagas Cardiomyopathy: Long-Term Follow-Up of Trypanosoma cruzi –Seropositive Individuals;Circulation;2021-11-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3